Announcements

We are delighted to share a collection of highly viewed papers in tumor microenvironment that were published in Cancers (ISSN: 2072-6694) in the first half of 2025. In addition, some Special Issues on this topic are currently open for submission. The following is a list of articles and Special Issues that we believe may be of interest to you:

The list of relevant papers can be seen below:

“Richness for Tumor-Infiltrating B-Cells in the Oral Cancer Tumor Microenvironment Is a Prognostic Factor in Early-Stage Disease and Improves Outcome in Advanced-Stage Disease”
by Irene H. Nauta, Dennis N. L. M. Nijenhuis, Sonja H. Ganzevles, Pamela I. Raaff, Jan Kloosterman, Elisabeth Bloemena, Ruud H. Brakenhoff, C. René Leemans and Rieneke van de Ven
Cancers 2025, 17(1), 113; https://doi.org/10.3390/cancers17010113
Available online: https://www.mdpi.com/2072-6694/17/1/113

“A Novel In Vitro Model of the Bone Marrow Microenvironment in Acute Myeloid Leukemia Identifies CD44 and Focal Adhesion Kinase as Therapeutic Targets to Reverse Cell Adhesion-Mediated Drug Resistance”
by Eleni E. Ladikou, Kim Sharp, Fabio A. Simoes, John R. Jones, Thomas Burley, Lauren Stott, Aimilia Vareli, Emma Kennedy, Sophie Vause and Timothy Chevassut et al.
Cancers 2025, 17(1), 135; https://doi.org/10.3390/cancers17010135
Available online: https://www.mdpi.com/2072-6694/17/1/135

“Metabolic Signaling in the Tumor Microenvironment”
by Ryan Clay, Kunyang Li and Lingtao Jin
Cancers 2025, 17(1), 155; https://doi.org/10.3390/cancers17010155
Available online: https://www.mdpi.com/2072-6694/17/1/155

“SSTR2-Targeted Theranostics in Hepatocellular Carcinoma”
by Majid Momeny, Solmaz AghaAmiri, Servando Hernandez Vargas, Belkacem Acidi, Sukhen C. Ghosh, Tyler M. Bateman, Jack T. Adams, Vahid Khalaj, Ahmed O. Kaseb, Hop S. Tran Cao et al.
Cancers 2025, 17(2), 162; https://doi.org/10.3390/cancers17020162
Available online: https://www.mdpi.com/2072-6694/17/2/162

“Differential Response to Local Stimulator of Interferon Genes Agonist Administration in Tumors with Various Stimulator of Interferon Genes Statuses”
by Alina Drzyzga, Justyna Czapla, Sybilla Matuszczak, Barbara Łasut-Szyszka, Tomasz Cichoń, Ewelina Pilny, Magdalena Jarosz-Biej and Ryszard Smolarczyk
Cancers 2025, 17(2), 175; https://doi.org/10.3390/cancers17020175
Available online: https://www.mdpi.com/2072-6694/17/2/175

“A Review of Telomere Attrition in Cancer and Aging: Current Molecular Insights and Future Therapeutic Approaches”
by Mina Iskandar, Miguel Xiao Barbero, Muhamed Jaber, Roy Chen, Romulo Gomez-Guevara, Edwin Cruz and Sandy Westerheide
Cancers 2025, 17(2), 257; https://doi.org/10.3390/cancers17020257
Available online: https://www.mdpi.com/2072-6694/17/2/257

You can view and submit relevant papers to Cancers via the following link:
https://www.mdpi.com/journal/cancers

Cancers Editorial Office

We are delighted to share a collection of highly viewed papers on infectious agents and cancer that were published in Cancers (ISSN: 2072-6694) in the first half of 2025. In addition, some Special Issues on this topic are currently open for submission. The following is a list of articles and Special Issues that we believe may be of interest to you:

The list of relevant papers can be seen below:

“An Assessment of Young Adults’ Awareness and Knowledge Related to the Human Papillomavirus (HPV), Oropharyngeal Cancer, and the HPV Vaccine”
by Eric N. Davis and Philip C. Doyle
Cancers 2025, 17(3), 344; https://doi.org/10.3390/cancers17030344
Available online: https://www.mdpi.com/2072-6694/17/3/344

“Human Papillomavirus-Related Cutaneous Squamous Cell Carcinoma”
by Alejandra Sandoval-Clavijo, Ignasí Martí-Martí, Carla Ferrándiz-Pulido, Júlia Verdaguer-Faja, Ane Jaka and Agustí Toll
Cancers 2025, 17(5), 897; https://doi.org/10.3390/cancers17050897
Available online: https://www.mdpi.com/2072-6694/17/5/897

“Involvement of Oral Microbiome in the Development of Oral Malignancy”
by Hitoshi Isono, Shintaro Nakajima, Satoshi Watanabe, Aya K. Takeda, Haruka Yoshii, Ami Shimoda, Hisao Yagishita, Kenji Mitsudo and Mitomu Kioi
Cancers 2025, 17(4), 632; https://doi.org/10.3390/cancers17040632
Available online: https://www.mdpi.com/2072-6694/17/4/632

“Ozone–Oxygen Therapy to Prevent HPV-Related Cancers of the Lower Gynecological Tract in Infected Patients: The Rationale for Further Developments”
by Luca Roncati
Cancers 2025, 17(3), 543; https://doi.org/10.3390/cancers17030543
Available online: https://www.mdpi.com/2072-6694/17/3/543

“Infectious Agents and Esophageal Cancer: A Comprehensive Review”
by Ahan Bhatt, Hasan Musanna Zaidi, Radhashree Maitra and Sanjay Goel
Cancers 2025, 17(7), 1248; https://doi.org/10.3390/cancers17071248
Available online: https://www.mdpi.com/2072-6694/17/7/1248

“Epstein–Barr Infection, Hodgkin’s Lymphoma, and the Immune System: Insights into the Molecular Mechanisms Facilitating Immune Evasion”
by Eleni Tsotridou and Emmanouel Hatzipantelis
Cancers 2025, 17(9), 1481; https://doi.org/10.3390/cancers17091481
Available online: https://www.mdpi.com/2072-6694/17/9/1481

You can view and submit relevant papers to Cancers via the following link:
https://www.mdpi.com/journal/cancers

Cancers Editorial Office

We are delighted to share a collection of highly viewed papers on cancer biomarkers that were published in Cancers (ISSN: 2072-6694) in the first half of 2025. In addition, some Special Issues on this topic are currently open for submission. The following is a list of articles and Special Issues that we believe may be of interest to you:

The list of relevant papers can be seen below:

“Artificial Intelligence-Assisted Drug and Biomarker Discovery for Glioblastoma: A Scoping Review of the Literature”
by Luana Conte, Gerardo Caruso, Anil K. Philip, Federico Cucci, Giorgio De Nunzio, Donato Cascio and Maria Caffo
Cancers 2025, 17(4), 571; https://doi.org/10.3390/cancers17040571
Available online: https://www.mdpi.com/2072-6694/17/4/571

“Exosome-Mediated Cellular Communication in the Tumor Microenvironment Imparts Drug Resistance in Breast Cancer”
by RamaRao Malla, Priyamvada Bhamidipati, Anuveda Sree Samudrala, Yerusha Nuthalapati, Vasudevaraju Padmaraju, Aditya Malhotra, Annah S. Rolig and Sanjay V. Malhotra
Cancers 2025, 17(7), 1167; https://doi.org/10.3390/cancers17071167
Available online: https://www.mdpi.com/2072-6694/17/7/1167

“Novel Urinary Biomarkers for the Detection of Bladder Cancer”
by Matthijs Oyaert, Charles Van Praet, Charlotte Delrue and Marijn M. Speeckaert
Cancers 2025, 17(8), 1283; https://doi.org/10.3390/cancers17081283
Available online: https://www.mdpi.com/2072-6694/17/8/1283

“Molecular Subtypes and Mechanisms of Breast Cancer: Precision Medicine Approaches for Targeted Therapies”
by Eduarda Carvalho, Sule Canberk, Fernando Schmitt and Nuno Vale
Cancers 2025, 17(7), 1102; https://doi.org/10.3390/cancers17071102  
Available online: https://www.mdpi.com/2072-6694/17/7/1102

“The Impact of Progesterone Receptor Status on Survival Outcomes in Metastatic Breast Cancer Patients Treated with First-Line CDK4/6 Inhibitors”
by Murad Guliyev, Ali Kaan Güren, Emre Özge, Rumeysa Çolak, Nargiz Majidova, Gülin Alkan Şen, Shamkhal Safarov, Murat Günaltılı, Mehmet Cem Fidan, İlkay Gültürk et al.
Cancers 2025, 17(4), 693; https://doi.org/10.3390/cancers17040693  
Available online: https://www.mdpi.com/2072-6694/17/4/693

“Evaluating Tumor Tissue Modified Viral (TTMV)-HPV DNA for the Early Detection of Anal Squamous Cell Carcinoma Recurrence”
by Rafi Kabarriti, Shane Lloyd, James Jabalee, Catherine Del Vecchio Fitz, Randa Tao, Tyler Slater, Corbin Jacobs, Sean Inocencio, Michael Rutenberg, Chance Matthiesen et al.
Cancers 2025, 17(2), 174; https://doi.org/10.3390/cancers17020174  
Available online: https://www.mdpi.com/2072-6694/17/2/174

Special Issues:

“Biomarkers for Gynecological Cancers”
Guest Editor: Dr. Apriliana Kartikasari
Submission deadline: 31 March 2026

“Predictive Biomarkers for Lung Cancer”
Guest Editor: Prof. Dr. Ole Hilberg
Submission deadline: 30 December 2025

“Biomarkers for Therapy Response in Gastrointestinal Malignancies: Predicting Outcomes and Personalizing Care”
Guest Editor: Dr. Devalingam Mahalingam
Submission deadline: 30 April 2026

“MicroRNA in Cancer: From Molecular Mechanisms to Therapeutic Applications”
Guest Editors: Prof. Dr. Girish Shukla and Dr. Sivakumar Vijayaraghavalu
Submission deadline: 31 May 2026

You can view and submit relevant papers to Cancers via the following link: https://www.mdpi.com/journal/cancers.

We are delighted to share a collection of highly viewed papers on cancer pathophysiology that were published in Cancers (ISSN: 2072-6694) in the first half of 2025. In addition, some Special Issues on this topic are currently open for submission. The following is a list of articles and Special Issues that we believe may be of interest to you:

“Exploring the Genetic Orchestra of Cancer: The Interplay Between Oncogenes and Tumor-Suppressor Genes”
by Sajal Raj Singh, Rakesh Bhaskar, Shampa Ghosh, Bhuvaneshwar Yarlagadda, Krishna Kumar Singh, Prashant Verma, Sonali Sengupta, Mitko Mladenov, Nikola Hadzi-Petrushev, Radoslav Stojchevski et al.
Cancers 2025, 17(7), 1082; https://doi.org/10.3390/cancers17071082
Available online: https://www.mdpi.com/2072-6694/17/7/1082

“Translational Advances in Oncogene and Tumor-Suppressor Gene Research”
by Radoslav Stojchevski, Edward Agus Sutanto, Rinni Sutanto, Nikola Hadzi-Petrushev, Mitko Mladenov, Sajal Raj Singh, Jitendra Kumar Sinha, Shampa Ghosh, Bhuvaneshwar Yarlagadda, Krishna Kumar Singh et al.
Cancers 2025, 17(6), 1008; https://doi.org/10.3390/cancers17061008
Available online: https://www.mdpi.com/2072-6694/17/6/1008

“The HOX Gene Family’s Role as Prognostic and Diagnostic Biomarkers in Hematological and Solid Tumors”
by Kaci Kopec, Danielle Quaranto, Nicole R. DeSouza, Tara Jarboe, Humayun K. Islam, Augustine Moscatello, Xiu-Min Li, Jan Geliebter and Raj K. Tiwari
Cancers 2025, 17(2), 262; https://doi.org/10.3390/cancers17020262
Available online: https://www.mdpi.com/2072-6694/17/2/262

“Unique Molecular Alteration of Lobular Breast Cancer: Association with Pathological Classification, Tumor Biology and Behavior, and Clinical Management”
by Huina Zhang and Yan Peng
Cancers 2025, 17(3), 417; https://doi.org/10.3390/cancers17030417
Available online: https://www.mdpi.com/2072-6694/17/3/417

“Curcumin and Its Derivatives in Hepatology: Therapeutic Potential and Advances in Nanoparticle Formulations”
by Ersin Karatayli, Shifana C. Sadiq, Jörn M. Schattenberg, Stephan Grabbe, Bernhard Biersack and Leonard Kaps
Cancers 2025, 17(3), 484; https://doi.org/10.3390/cancers17030484
Available online: https://www.mdpi.com/2072-6694/17/3/484

“Histotripsy of Liver Tumors: Patient Selection, Ethical Discussions, and How We Do It”
by Melis Uysal, Chase J. Wehrle, Sangeeta Satish, Emily Knott, Hanna Hong, Erlind Allkushi, Andrea Schlegel, Eren Berber, Federico Aucejo, JaeKeun Kim et al.
Cancers 2025, 17(7), 1100; https://doi.org/10.3390/cancers17071100
Available online: https://www.mdpi.com/2072-6694/17/7/1100

Special Issues
“Extracellular Matrix—Role in the Tumor Microenvironment and Impact on Cancer Therapy” Guest Editors: Dr. Heena Kumra and Dr. Makoto Noda Submission deadline: 30 April 2026	“Advances in Pathology of Lymphoma and Leukemia” Guest Editor: Dr. Siba El Hussein Submission deadline: 31 March 2026
“Genetics and Epigenetics of Gynecological Cancer” Guest Editor: Dr. Carmela De Marco Submission deadline: 31 January 2026	“Pathology and Treatment of Triple-Negative Breast Cancer” Guest Editor: Dr. Ramadevi Subramani Submission deadline: 31 January 2026

You can view and submit relevant papers to Cancers via the following link: https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

We are delighted to share a collection of highly viewed papers on systematic review or meta-analysis in cancer research that were published in Cancers (ISSN: 2072-6694) in the first half of 2025. In addition, some Special Issues on this topic are currently open for submission. The following is a list of articles and Special Issues that we believe may be of interest to you:

The list of relevant papers can be seen below:

“Robotic Versus Laparoscopic Adrenalectomy for Adrenal Tumors: An Up-to-Date Meta-Analysis on Perioperative Outcomes”
by Giuseppe Esposito, Barbara Mullineris, Giovanni Colli, Serena Curia and Micaela Piccoli
Cancers 2025, 17(1), 150; https://doi.org/10.3390/cancers17010150
Available online: https://www.mdpi.com/2072-6694/17/1/150

“Pancreaticobiliary Maljunction and Its Relationship with Biliary Cancer: An Updated and Comprehensive Systematic Review and Meta-Analysis on Behalf of TROGSS—The Robotic Global Surgical Society”
by Yeisson Rivero-Moreno, Aman Goyal, Victor Bolívar, Nnenna Osagwu, Sophia Echevarria,
José Gasca-Insuasti, Freddy Pereira-Graterol, Dagny von Ahrens, Omar Felipe Gaytán Fuentes, Luis Osvaldo Suárez-Carreón et al.
Cancers 2025, 17(1), 122; https://doi.org/10.3390/cancers17010122   
Available online: https://www.mdpi.com/2072-6694/17/1/122

“Impact of Physical Exercise on Breast Cancer-Related Lymphedema and Non-Invasive Measurement Tools: A Systematic Review”
by Marta Arias-Crespo, Rubén García-Fernández, Natalia Calvo-Ayuso, Cristian Martín-Vázquez, Maria de Fátima da Silva Vieira Martins and Enedina Quiroga-Sánchez
Cancers 2025, 17(2), 333; https://doi.org/10.3390/cancers17020333
Available online: https://www.mdpi.com/2072-6694/17/2/333

“Evaluating Tumour Mutational Burden as a Key Biomarker in Personalized Cancer Immunotherapy: A Pan-Cancer Systematic Review”
by Anca Zgura, Stefania Chipuc, Nicolae Bacalbasa, Bogdan Haineala, Anghel Rodica and Vâlcea Sebastian
Cancers 2025, 17(3), 480; https://doi.org/10.3390/cancers17030480
Available online: https://www.mdpi.com/2072-6694/17/3/480

“Dark Topics on Giant Retroperitoneal Liposarcoma: A Systematic Review of 157 Cases”
by Alfonso Santangelo, Agostino Fernicola, Domenico Santangelo, Gaia Peluso, Armando Calogero, Felice Crocetto, Akbar Jamshidi, Luigi Pelosio, Alessandro Scotti, Vincenzo Tammaro et al.
Cancers 2025, 17(5), 740; https://doi.org/10.3390/cancers17050740
Available online: https://www.mdpi.com/2072-6694/17/5/740

“Immune Checkpoint Inhibitor-Induced Pancreatic Injury (ICI-PI) in Adult Cancer Patients: A Systematic Review and Meta-Analysis”
by Cha Len Lee, Israt Jahan Riya, Ifrat Jahan Piya, Thiago Pimentel Muniz, Marcus Otho Butler and Samuel David Saibil
Cancers 2025, 17(7), 1080; https://doi.org/10.3390/cancers17071080
Available online: https://www.mdpi.com/2072-6694/17/7/1080

Special Issue:

“Systematic Reviews and Meta-Analyses of Genitourinary Cancers (2nd Edition)”
Guest Editors: Prof. Dr. Giorgio Treglia and Dr. Ursula Maria Vogl
Submission deadline: 31 July 2026

You can view and submit relevant papers to Cancers via the following link: https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

We are delighted to share a collection of highly viewed papers in clinical research of cancer that were published in Cancers (ISSN: 2072-6694) in the first half of 2025. In addition, some Special Issues on this topic are currently open for submission. The following is a list of articles and Special Issues that we believe may be of interest to you:

“Evaluating Offspring After Pregnancy-Associated Cancer: A Systematic Review of Neonatal Outcomes”
by Aida Petca, Lucia Elena Niculae, Raluca Tocariu, Aniela-Roxana Nodiți, Răzvan-Cosmin Petca and Ioana Cristina Rotar
Cancers 2025, 17(2), 299; https://doi.org/10.3390/cancers17020299
Available online: https://www.mdpi.com/2072-6694/17/2/299

“Treatment Quality of Rectal Cancer Patients in Certified Colorectal Cancer Centers Versus Non-Certified Hospitals: A Comparative Analysis”
by Paweł Mroczkowski, Henry Kusian, Olof Jannasch, Hans Lippert, Radosław Zajdel, Karolina Zajdel, Arkadiusz Sadowski and Anna Merecz-Sadowska
Cancers 2025, 17(1), 120; https://doi.org/10.3390/cancers17010120
Available online: https://www.mdpi.com/2072-6694/17/1/120

“Maxillectomy Guided by 3D Printing Versus Conventional Surgery for Patients with Head and Neck Cancer”
by Sung Yool Park, Sung Ha Jung, Anna Seo, Hakjong Noh, Hwansun Lee, Hyo Jun Kim, Younghac Kim, Man Ki Chung, Han-Sin Jeong, Chung-Hwan Baek et al.
Cancers 2025, 17(1), 140; https://doi.org/10.3390/cancers17010140
Available online: https://www.mdpi.com/2072-6694/17/1/140

“UBR5 in Tumor Biology: Exploring Mechanisms of Immune Regulation and Possible Therapeutic Implications in MPNST”
by Diana Akinyi Odhiambo, Selina Fan and Angela C. Hirbe
Cancers 2025, 17(2), 161; https://doi.org/10.3390/cancers17020161
Available online: https://www.mdpi.com/2072-6694/17/2/161

“A Sequencing Overview of Malignant Peripheral Nerve Sheath Tumors: Findings and Implications for Treatment”
by Kangwen Xiao, Kuangying Yang and Angela C. Hirbe
Cancers 2025, 17(2), 180; https://doi.org/10.3390/cancers17020180
Available online: https://www.mdpi.com/2072-6694/17/2/180

“Clinical Benefit of Pegylated Liposomal Doxorubicin and High Prevalence of Pre-Existing Psychiatric Conditions in Patients with Desmoid-Type Fibromatosis”
by Andrea Espejo Freire and Keith M. Skubitz
Cancers 2025, 17(2), 293; https://doi.org/10.3390/cancers17020293
Available online: https://www.mdpi.com/2072-6694/17/2/293

Special Issues
“Advances in Spine Oncology: Research and Clinical Studies” Guest Editor: Dr. Oluwaseun O. Akinduro Submission deadline: 31 December 2025	“Gynecological Cancer: Prevention, Diagnosis, Prognosis and Treatment” Guest Editors: Dr. Joanna P. Kacperczyk-Bartnik, Dr. Tibor Andrea Zwimpfer and Prof. Dr. Michał Ciebiera Submission deadline: 20 December 2025
“Optimizing Surgical Procedures and Outcomes in Renal Cancer” Guest Editors: Prof. Dr. Maciej Salagierski and Dr. Piotr Kania Submission deadline: 20 December 2025	“Advances in Clinical Trials: Outcome, Innovations, Challenges, and Ethical Practice. in Cancer Research 2024–2025” Guest Editors: Prof. Dr. Naoto T. Ueno and Prof. Dr. David R. Gandara Submission deadline: 31 December 2025

You can view and submit relevant papers to Cancers via the following link: https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

We are delighted to share a collection of highly viewed papers on cancer causes, screening and diagnosis that were published in Cancers (ISSN: 2072-6694) in the first half of 2025. In addition, some Special Issues on this topic are currently open for submission. The following is a list of articles and Special Issues that we believe may be of interest to you:

“Innovative Approaches to Early Detection of Cancer-Transforming Screening for Breast, Lung, and Hard-to-Screen Cancers”
by Shlomi Madar, Reef Einoch Amor, Sharon Furman-Assaf and Eitan Friedman
Cancers 2025, 17(11), 1867; https://doi.org/10.3390/cancers17111867
Available online: https://www.mdpi.com/2072-6694/17/11/1867

“Glioblastoma: Clinical Presentation, Multidisciplinary Management, and Long-Term Outcomes”
by David Sipos, Bence L. Raposa, Omar Freihat, Mihály Simon, Nejc Mekis, Patrizia Cornacchione and Árpád Kovács
Cancers 2025, 17(1), 146; https://doi.org/10.3390/cancers17010146
Available online: https://www.mdpi.com/2072-6694/17/1/146

“Targeting Immune Checkpoint Inhibitors for Non-Small-Cell Lung Cancer: Beyond PD-1/PD-L1 Monoclonal Antibodies”
by Nicolas Roussot, Courèche Kaderbhai and François Ghiringhelli
Cancers 2025, 17(5), 906; https://doi.org/10.3390/cancers17050906
Available online: https://www.mdpi.com/2072-6694/17/5/906

“Advances in Glioblastoma Diagnosis: Integrating Genetics, Noninvasive Sampling, and Advanced Imaging”
by Ryan Gough, Randall W. Treffy, Max O. Krucoff and Rupen Desai
Cancers 2025, 17(1), 124; https://doi.org/10.3390/cancers17010124
Available online: https://www.mdpi.com/2072-6694/17/1/124

“Rising Trends in Prostate Cancer Among Asian Men: Global Concerns and Diagnostic Solutions”
by Li-Chuan Ko, Nick Gravina, Joos Berghausen and Joe Abdo
Cancers 2025, 17(6), 1013; https://doi.org/10.3390/cancers17061013
Available online: https://www.mdpi.com/2072-6694/17/6/1013

“Exosomes in Precision Oncology and Beyond: From Bench to Bedside in Diagnostics and Therapeutics”
by Emile Youssef, Dannelle Palmer, Brandon Fletcher and Renee Vaughn
Cancers 2025, 17(6), 940; https://doi.org/10.3390/cancers17060940
Available online: https://www.mdpi.com/2072-6694/17/6/940

Special Issues:

“Advances in Diagnostics and Treatments for Glioblastoma” Guest Editors: Dr. Sied Kebir and Dr. Manmeet Singh Ahluwalia Submission deadline: 10 April 2026	“Mass Spectrometry and Cancers” Guest Editors: Dr. Rita Casadonte and Dr. Kristina Schwamborn Submission deadline: 15 May 2026
“Breast Cancer Screening: Global Practices and Future Directions” Guest Editor: Dr. Rudolf Morant Submission deadline: 15 May 2026	“Digital Pathology in Precision Oncology: Emerging Tools for Diagnosis and Treatment Guidance” Guest Editors: Dr. Daniela Hartmann and Dr. Maximilian Deussing Submission deadline: 25 June 2026

You can view and submit relevant papers to Cancers via the following link: https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

We are pleased to announce that eight new scholars have been appointed Editorial Board Members (EBMs) of Cancers (ISSN: 2072-6694), joining in October 2025. We wish our new members success in both their research and their efforts to develop the journal.

Further details about the Editorial Board of Cancers can be found by clicking the following link: https://www.mdpi.com/journal/cancers/editors.

Cancers is recruiting scholars from around the world to join our Editorial Board. To apply for membership, recommend potential candidates, or request further information, please contact the Cancers Editorial Office and provide the following files:

• A full academic CV;
• A short cover letter that details your interest in the position.

Nine new journals covering a range of subjects launched their inaugural issues in September 2025. We are excited to be able to share with you the newest research rooted in the value of open access.

We extend our sincere thanks to all Editorial Board Members for their commitment and expertise. Each journal is dedicated to upholding strong editorial standards through a thorough peer review process, ensuring impactful open access scholarship.

Please feel free to browse and discover more about the new journals below.

We would like to thank everyone who has supported the development of open access publishing. If you would like to create more new journals, you are welcome to send an application here, or contact the New Journal Committee (newjournal-committee@mdpi.com).

We are delighted to share some highly cited papers on thyroid cancer published in 2024 in Cancers (ISSN: 2072-6694).

The list of highly cited papers can be viewed below:

“Improvement in Central Neck Dissection Quality in Thyroid Cancer by Use of Tissue Autofluorescence”
by Octavian Constantin Neagoe and Mihaela Ionică
Cancers 2024, 16(2), 258; https://doi.org/10.3390/cancers16020258

“Association of HOTAIR, MIR155HG, TERC, miR-155, -196a2, and -146a Genes Polymorphisms with Papillary Thyroid Cancer Susceptibility and Prognosis”
by Jelena Karajovic, Bozidar Kovacevic, Bojana Uzelac, Debora Stefik, Bojana Jovanovic, Petar Ristic, Snezana Cerovic and Gordana Supic
Cancers 2024, 16(3), 485; https://doi.org/10.3390/cancers16030485

“How [¹⁸F]FDG-PET/CT Affects the Management of Patients with Differentiated Thyroid Carcinoma in Clinical Routines”
by Jonas Vogel, Julia Sekler, Brigitte Gückel, Christina Pfannenberg, Konstantin Nikolaou, Christian La Fougère, Helmut Dittmann and Christian Philipp Reinert
Cancers 2024, 16(3), 588; https://doi.org/10.3390/cancers16030588

“FAPi-Based Agents in Thyroid Cancer: A New Step towards Diagnosis and Therapy? A Systematic Review of the Literature”
by Priscilla Guglielmo, Pierpaolo Alongi, Lucia Baratto, Miriam Conte, Elisabetta Maria Abenavoli, Ambra Buschiazzo, Greta Celesti, Francesco Dondi, Rossella Filice, Joana Gorica et al.
Cancers 2024, 16(4), 839; https://doi.org/10.3390/cancers16040839

“Latest Progress in Risk-Adapted Surgery for Medullary Thyroid Cancer”
by Andreas Machens, Kerstin Lorenz, Tim Brandenburg, Dagmar Führer, Frank Weber and Henning Dralle
Cancers 2024, 16(5), 917; https://doi.org/10.3390/cancers16050917

“Advances in the Development of Positron Emission Tomography Tracers for Improved Detection of Differentiated Thyroid Cancer”
by Hannelore Iris Coerts, Bart de Keizer and Frederik Anton Verburg
Cancers 2024, 16(7), 1401; https://doi.org/10.3390/cancers16071401

“The Utility of Contrast-Enhanced Ultrasound (CEUS) in Assessing the Risk of Malignancy in Thyroid Nodules”
by Agnieszka Żyłka, Katarzyna Dobruch-Sobczak, Hanna Piotrzkowska-Wróblewska, Maciej Jędrzejczyk, Elwira Bakuła-Zalewska, Piotr Góralski, Jacek Gałczyński and Marek Dedecjus
Cancers 2024, 16(10), 1911; https://doi.org/10.3390/cancers16101911

“Current and Future of Robotic Surgery in Thyroid Cancer Treatment”
by Joonseon Park and Kwangsoon Kim
Cancers 2024, 16(13), 2470; https://doi.org/10.3390/cancers16132470

“Pre-Operative Calcitonin and CEA Values May Predict the Extent of Metastases to the Lateral Neck Lymph Nodes in Patients with Medullary Thyroid Cancer”
by Antonio Prinzi, Francesco Frasca, Marco Russo, Gabriella Pellegriti, Tommaso Piticchio, Dario Tumino, Antonino Belfiore and Pasqualino Malandrino
Cancers 2024, 16(17), 2979; https://doi.org/10.3390/cancers16172979

“The Value of Pretherapeutic Basal Calcitonin Cut-Offs for the Therapeutic Strategy and Prediction of Long-Term Outcome of Patients with Medullary Thyroid Cancer—A 30-Year Single-Center Experience”
by Martin B. Niederle, Teresa Binter, Philipp Riss, Bruno Niederle and Christian Scheuba
Cancers 2024, 16(19), 3343; https://doi.org/10.3390/cancers16193343

“Explainable Thyroid Cancer Diagnosis Through Two-Level Machine Learning Optimization with an Improved Naked Mole-Rat Algorithm”
by Wojciech Książek
Cancers 2024, 16(24), 4128; https://doi.org/10.3390/cancers16244128

The list of relevant Special Issues can be viewed below:

“Thyroid Cancer: New Advances from Diagnosis to Therapy: 2nd Edition” Guest Editor: Prof. Dr. Michael Kreißl Submission deadline: 20 November 2025	“New Advances and Approaches in Thyroid Cancer” Guest Editors: Prof. Dr. Beatriz Febrero and Prof. Dr. José Manuel Rodríguez Submission deadline: 31 August 2026

You are welcome to submit relevant papers to Cancers.

Cancers Editorial Office